-
公开(公告)号：EP1581640A2
公开(公告)日：2005-10-05
申请号：EP03785433.8
申请日：2003-12-24
Applicant: An-Go-Gen Inc. , Stewart, Duncan J. , Courtman, David , Karoubi, Golnaz
CPC classification number: A61K9/5036 , A61K35/12 , C12N5/0656 , C12N5/0663 , C12N11/04 , C12N2533/52 , C12N2533/56 , C12N2533/76
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
公开(公告)号：AU2003294540A1
公开(公告)日：2004-07-22
申请号：AU2003294540
申请日：2003-12-24
Applicant: COURTMAN DAVID , NORTHERN THERAPEUTICS INC , STEWART DUNCAN J , BABAEI SAEID
Inventor： COURTMAN DAVID , STEWART DUNCAN J , BABAEI SAEID
IPC: A61K31/198 , A61K31/216 , A61K38/17 , A61K38/18 , A61K48/00 , C12N9/02
Abstract: Early onset of pulmonary disorders such as pulmonary hypertension are treated or prevented by administration of an apoptosis inhibitor or a survival factor. Early onset of such disorders may be diagnosed by assessing apoptosis in lung tissue.
-
公开(公告)号：AU2003294541A1
公开(公告)日：2004-07-22
申请号：AU2003294541
申请日：2003-12-24
Applicant: STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ , AN GO GEN INC
Inventor： STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
公开(公告)号：CA385179A
公开(公告)日：1939-11-21
申请号：CA385179D
Applicant: STEWART DUNCAN J
Inventor： STEWART DUNCAN J
-
Patent Agency Ranking
公开(公告)号：CA385180A
公开(公告)日：1939-11-21
申请号：CA385180D
Applicant: STEWART DUNCAN J
Inventor： STEWART DUNCAN J
-
公开(公告)号：WO2004058305A3
公开(公告)日：2004-07-15
申请号：PCT/CA2003/002008
申请日：2003-12-24
Applicant: AN-GO-GEN INC. , STEWART, Duncan, J. , COURTMAN, David , KAROUBI, Golnaz
Inventor： STEWART, Duncan, J. , COURTMAN, David , KAROUBI, Golnaz
IPC: C12N11/04
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
公开(公告)号：WO2004058305A2
公开(公告)日：2004-07-15
申请号：PCT/CA0302008
申请日：2003-12-24
Applicant: AN GO GEN INC , STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
Inventor： STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
CPC classification number: A61K9/5036 , A61K35/12 , C12N5/0656 , C12N5/0663 , C12N11/04 , C12N2533/52 , C12N2533/56 , C12N2533/76
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
Abstract translation: 细胞疗法包括用整联蛋白或其它细胞相互作用因子包封细胞，用于给予哺乳动物。 细胞可以表达治疗性转基因，或细胞可以是再生的。
-
8.发明申请METHODS OF DIAGNOSING, PREVENTING, AND TREATING EARLY ONSET OF PULMONARY HYPERTENSION 审中-公开诊断，预防和治疗早期高血压的方法
公开(公告)号：WO2004058293A1
公开(公告)日：2004-07-15
申请号：PCT/CA2003/002007
申请日：2003-12-24
Applicant: NORTHERN THERAPEUTICS INC. , STEWART, Duncan, J. , BABAEI, Saeid , COURTMAN, David
Inventor： STEWART, Duncan, J. , BABAEI, Saeid , COURTMAN, David
IPC: A61K38/18
CPC classification number: A61K31/216 , A61K31/198 , A61K38/06 , A61K38/1866 , A61K38/1891 , A61K38/44 , A61K48/005 , C12Y114/13039
Abstract: Early onset of pulmonary disorders such as pulmonary hypertension are treated or prevented by administration of an apoptosis inhibitor or a survival factor. Early onset of such disorders may be diagnosed by assessing apoptosis in lung tissue.
Abstract translation: 通过施用凋亡抑制剂或存活因子来治疗或预防肺部疾病如肺动脉高压的早期发作。 可以通过评估肺组织中的细胞凋亡来诊断此类疾病的早期发作。
-
公开(公告)号：US2549030A
公开(公告)日：1951-04-17
申请号：US77011447
申请日：1947-08-22
Applicant: STEWART DUNCAN J
Inventor： STEWART DUNCAN J
IPC: F41G5/08
CPC classification number: F41G5/08
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.034 seconds)
